Thyroid hormones (THs) act on cells of almost all tissues and therefore are involved in several physiologic processes during a life span. In adults, THs are mainly involved in metabolic activities such as protein, lipid, and carbohydrate metabolism and heat generation ([@b22-ehp-117-1380]). They are also necessary for normal reproductive functions, regulation of heart rate, and gastrointestinal motility, as well as for emotional stability ([@b5-ehp-117-1380]; [@b8-ehp-117-1380]). Disruptions of thyroid function by endogenous (e.g., auto-antibodies) or exogenous (e.g., iodine) factors may produce various subclinical effects ([@b34-ehp-117-1380]) or direct clinical manifestations. Consequently, there are concerns regarding the ubiquitous background chronic exposure of human populations to polyhalogenated compounds (PHCs), a group of chemicals that include legacy and emerging persistent organic pollutants that have been shown or are suspected to have thyroid-disrupting properties ([@b9-ehp-117-1380]; [@b10-ehp-117-1380]; [@b11-ehp-117-1380]; [@b18-ehp-117-1380]; [@b20-ehp-117-1380]; [@b38-ehp-117-1380]).

Several epidemiologic studies aimed to evaluate the effects of dioxin-like compounds (DLCs), polychlorinated biphenyls (PCBs), and some organochlorine pesticides (OCPs) on TH homeostasis in adults ([@b1-ehp-117-1380]; [@b15-ehp-117-1380]). Effects of these compounds on TSH concentrations were variable, whereas several studies found a negative relationship with total thyroxine (tT~4~) and/or total triiodothyronine (tT~3~), without a significant change on free thyroxine (fT~4~) levels. The relationship between hydroxylated metabolites of PCBs (HO-PCBs) and TH status in adults was studied only in fishermen from the Baltic Sea, and no association was found ([@b16-ehp-117-1380]). With regard to polybrominated diphenyl ethers (PBDEs), studies investigating the thyroid-disrupting potential of these flame retardants in populations exposed to background levels are scarce, inconsistent, and limited to male populations ([@b7-ehp-117-1380]; [@b16-ehp-117-1380]; [@b19-ehp-117-1380]; [@b36-ehp-117-1380]). On the other hand, potential effects of perfluoro-octanesulfonate (PFOS) on THs in an environmentally exposed adult population have been investigated only in one small study in which no significant association was observed with either TSH or fT~4~ ([@b6-ehp-117-1380]).

Nunavik Inuit are exposed to relatively high concentrations of PCBs and other organo-chlorines (OCs) through their seafood-based traditional diet compared with populations from southern regions of North America. Considering the thyroid-disrupting potential of these contaminants, the aim of the present study was to investigate the relationship between several PHCs and thyroid function in the Inuit adult population of Nunavik.

Materials and Methods
=====================

Population, study design, and data collection
---------------------------------------------

We conducted a comprehensive health cross-sectional study in the Inuit population of Nunavik (Québec, Canada) from 27 August to 1 October 2004. The target population of this study was permanent Inuit residents of Nunavik ≥ 18 years of age. We used a stratified random sampling of private Inuit households, with the community being the stratification variable. The study was approved by the Comité d'éthique de la recherche de l'Université Laval and the Comité d'éthique de santé publique du Québec. All participants provided written consent before taking part in the study.

Several self-administered and interviewer-completed questionnaires were used to obtain information regarding demographics, lifestyle habits, and nutrition. In addition, individuals were asked to participate in a clinical session where blood samples were taken and physical measurements were performed. Overall, the participation rate for the different collection instruments was approximately 50%, for a total of 1,056 participants. We assessed contaminant concentrations on 889 plasma samples. Because TH concentrations fluctuate greatly during pregnancy, we excluded pregnant women from the present study (*n* = 23). Non-Inuit (*n* = 20) and individuals using medication for thyroid diseases (*n* = 19) were also excluded.

Demographic, clinical, and nutritional variables
------------------------------------------------

We obtained data related to education, income, and cigarette consumption through an interviewer-administered questionnaire; information on alcohol consumption was obtained from a questionnaire completed confidentially by the participant. We obtained data regarding medication use in the 6 months preceding the study from medical charts. Among participants with quantified concentrations of contaminants, 729 had completed questionnaires regarding sociodemographic information, and 628 had records of medication consumption. Data on fish consumption were obtained using a food frequency questionnaire from 536 participants with quantified PHC concentrations. Details regarding the calculation of fish consumption are described in Supplemental Material available online (doi:10.1289/ehp.0900633.S1 via <http://dx.doi.org/>).

Laboratory procedures
---------------------

Blood samples (60 mL) were collected using a venous catheter from an antecubital vein. Tubes were centrifuged within 3 hr of collection and plasma was isolated, aliquoted, and frozen at −80°C before clinical biochemistry and contaminant analyses. We analyzed plasma samples for PCBs and their hydroxylated (HO) and methylsulfonyl (MeSO~2~) metabolites, OCPs, halogenated phenolic compounds, and PBDEs according to a multiresidue gas chromatography/mass spectrometry (MS) method. Plasma samples were also analyzed for PFOS using liquid chromatography/MS and for DLCs using a reporter gene bioassay. See the Supplemental Material (doi:10.1289/ehp.0900633.S1) for details of these laboratory procedures.

We report plasma concentrations of PCBs, PBDEs OCPs, and DLCs on a lipid basis. Cholesterol and triglyceride analyses were conducted using a Hitachi 917 auto analyzer and reagents from Roche Diagnostics (Indianapolis, IN, USA). Concentrations of total plasma lipids were estimated from cholesterol and triglyceride levels according to the formula developed by [@b28-ehp-117-1380].

We determined selenium concentrations in whole blood by inductively coupled plasma MS. Samples were diluted in ammonium hydroxide and then analyzed on an Elan 6000 instrument (Perkin Elmer-Sciex, Ontario, Canada). The limit of detection (LOD) was 0.09 μmol/L, and the coefficient of variation (CV) was 7.9% for a reference specimen (3.3 μmol/L) analyzed on 10 different days.

Analyses of serum thyroid-stimulating hormone (TSH), fT~4~, tT~3,~ and thyroxine-binding globulin (TBG; the major transport protein of TH), were performed using radioimmunoassay methods. We measured TSH, fT~4~, and tT~3~ on the Elecsys 1010/2010 analyzers and the Modular Analytics E170 immunoassay module (Roche Diagnostics). The interassay CVs were 2.0% for TSH, 4.7% for fT~4~, and 3.3% for tT~3~. TBG, determined using the Clinical Assays GammaDab system commercialized by DiaSorin (Stillwater, MN, USA), had an inter-assay CV of 3.6%.

Statistical analysis
--------------------

We determined potential effects of contaminants on thyroid status for PHCs with a detection frequency \> 70%, except for BDE-47, which was detected in 57% of samples. We included BDE-47 regardless of detection frequency because of the growing concern regarding the rapid increase in concentrations measured in human samples in North America and because of its toxicologic properties. Parameters were estimated randomly from a log-normal distribution using the maximum likelihood estimation for samples with concentrations of contaminants below LODs of the analytical procedures. The multiple imputation method was an adequate statistical approach compared with the assignment of a value equal to LOD/2 when non detected values represent \> 5% of the sample ([@b23-ehp-117-1380]). Effects of PCB congeners were assessed individually or as a group for mono-*ortho* PCBs (PCBs 74, 105, 118, and 156). We examined the relationship of environmental contaminants with THs (TSH, fT~4~, and tT~3~) and TBG by simple and multiple linear regression models. Contaminant concentrations and thyroid parameters were all log-transformed to satisfy criteria of normality. Five participants with extreme values of TSH were excluded.

Interaction terms between sex and all contaminants in relation to TH concentrations were tested in full models. Because all interaction terms were nonsignificant, we examined effects of PHCs on the TH homeo stasis in men and women jointly. We tested covariates known as risk factors for thyroid diseases or suspected to be associated with TH parameters to determine if they should be included in regression models. Covariates associated at a *p*-value ≤ 0.10 were included in multiple regression models to assess their confounding influence. Covariates are presented in [Table 1](#t1-ehp-117-1380){ref-type="table"} and are expressed as continuous variables, except where noted. Some participants declared taking medication known to alter thyroid function tests, including estrogen formulations, heparin, beta-blockers, furosemide, nonsteroidal anti-inflammatory agents, glucocorticoids, anticonvulsants, dopaminergics, and carboxamides. We created a dichotomous variable to account for the consumption of those medications. Covariates that modified the regression coefficient of the contaminants with any of the THs by \> 10% were included in adjusted models. However, considering that data concerning alcohol and fish consumption were missing for 42 and 92 participants, respectively, and that their confounding effects were observed for a small proportion of associations, their inclusion in regression models was not systematic. We evaluated multicollinearity for all multiple regression models. Also, a contaminant in each family of PHCs (PCB-153, BDE-47, and PFOS) was selected and introduced together in multiple models to assess their influence on the associations with the contaminants under study.

We used sample weights to account for the complex sampling method and to obtain appropriate SEs and *p*-values. We considered a bilateral *p*-value \< 0.05 statistically significant. Statistical analyses were performed with SAS (version 9.1; SAS Institute Inc., Cary, NC, USA) and SUDAAN software (version 9.0.1; Research Triangle Institute, Research Triangle Park, NC, USA).

Results
=======

Sociodemographic, personal, and clinical characteristics of participants are presented in [Table 1](#t1-ehp-117-1380){ref-type="table"}. Most participants had TH concentrations in the laboratory test euthyroid range (TSH, 95.0%; fT~4~, 96.5%; tT~3~, 99.2%; TBG, 86.3%). Plasma concentrations of PHCs measured in adult Inuit are shown in [Table 2](#t2-ehp-117-1380){ref-type="table"}. Concentrations of all PCB congeners were highly intercorrelated (*r* = 0.71--0.98; *p* \< 0.001) and were strongly correlated with their metabolites \[for the sum of PCBs (∑PCBs) and ∑HO-PCBs, *r* = 0.94; for ∑PCBs and ∑MeSO~2~-PCBs, *r* = 0.90; *p* \< 0.001\]. ∑PCB was less strongly correlated with DLC concentration (*r* = 0.69; *p* \< 0.001) but still highly correlated with concentrations of OCPs (*r* = 0.85--0.95; *p* \< 0.001). Pentachlorophenol was not correlated with any contaminant. Plasma concentrations of BDE-47 were moderately correlated with BDE-153 levels (*r* = 0.36; *p* \< 0.001) but were not correlated with those of other contaminants. Plasma concentrations of PFOS were moderately correlated with those of PCB congeners and their metabolites (*r* = 0.47--0.55; *p* \< 0.001), other OCs (*r* = 0.36--0.51; *p* \< 0.001), and BDE-153 (*r*= 0.22; *p*\< 0.001) but not with BDE-47.

Associations between contaminant plasma concentrations and TH concentrations are presented in [Tables 3](#t3-ehp-117-1380){ref-type="table"}--[5](#t5-ehp-117-1380){ref-type="table"}. Associations with further adjustment for exposure to other families of contaminants are presented in Supplemental Material, Tables S1--S3 (doi:10.1289/ehp.0900633.S1). We observed significant negative associations between the more highly chlorinated PCB congeners and TSH in multiple linear regression models ([Table 3](#t3-ehp-117-1380){ref-type="table"}). We found no association between concentrations of PCB congeners or their groupings and fT~4~ levels in adjusted models. Fourteen PCB congeners, ∑PCBs, and the mono-*ortho* PCB group, as well as the DLCs, were negatively associated with tT~3~ concentrations in multiple models. Further adjustment for fish consumption weakened associations with some PCB congeners and groupings. We observed significant negative associations between TBG concentrations and less-chlorinated PCBs as well as the mono-*ortho* PCB group grouping in adjusted models. The significance of some associations disappeared after controlling for fish and alcohol consumption. Also, adjustment for other families of contaminants weakened some associations with TSH, tT~3~, and TBG while revealing significant negative associations of PCB-118 and mono-*ortho* PCB congeners with fT~4~ concentrations \[Supplemental Material, Table S1 (doi:10.1289/ehp.0900633.S1)\].

HO-PCBs and MeSO~2~-PCBs were not significantly associated with TSH and fT~4~ concentrations in multiple models, except for HO-PCB-199 and HO-PCB-208, which were negatively related to TSH ([Table 4](#t4-ehp-117-1380){ref-type="table"}). Seven HO-PCBs, the ∑HO-PCBs, three MeSO~2~-PCBs, and the ∑MeSO~2~-PCBs were all significantly associated with a decrease in tT~3~ concentrations. We also found significant negative associations between TBG and five HO-PCBs and the ∑HO-PCBs. Only the associations for HO-PCB-107 and ∑HO-PCBs remained significant after controlling for fish consumption. Control for the exposure to other families of contaminants weakened some associations with tT~3~ and TBG but revealed significant negative associations of all MeSO~2~-PCBs metabolites and their sum (∑MeSO~2~-PCBs) with fT~4~ levels \[Supplemental Material, Table S2 (doi:10.1289/ehp.0900633.S1)\].

Plasma concentrations of OCPs were not significantly associated with TSH levels ([Table 5](#t5-ehp-117-1380){ref-type="table"}). Also, among OCPs, only hexachlorobenzene (HCB) concentrations were negatively associated with fT~4~ circulating levels, whereas this compound and β-hexachlorocyclohexane (β-HCH) were negatively related to tT~3~ concentrations. TBG concentrations were negatively associated with all OCPs, except for pentachloro phenol in multiple models. Further adjustments for alcohol consumption had no impact on the relationship between OCPs and TH parameters, except for TBG, for which only the associations with HCB and β-HCH remained significant. Adjustment for other families of contaminants revealed a significant positive association between β-HCH and TSH levels \[see Supplemental Material, Table S3 (doi:10.1289/ehp.0900633.S1)\]. Pentachlorophenol plasma concentrations were not associated with any of the TH parameters. Among PBDEs, only BDE-47 was positively associated with tT~3~ concentrations in multiple models. This association weakened after controlling for fish consumption. We observed a significant negative association for PFOS concentrations with TSH, tT~3~, and TBG circulating levels, whereas we found a positive association with fT~4~ levels. Adjustment for other potential confounders and families of contaminants weakened the association with tT~3~ concentrations.

Discussion
==========

Our findings in the present study suggest modifications of the thyroid parameters in adult Inuit by PHCs. This is the first large-scale study investigating the effect of PFOS on TH homeostasis in an environmentally exposed adult population. We observed significant negative associations of PFOS concentrations with TSH, tT~3~, and TBG levels, whereas we found a positive association with fT~4~ concentrations. Furthermore, although exposure to BDE-47 in Inuit adults is lower than that in other North American populations, we found a positive association of tT~3~ with increasing concentrations BDE-47. Several PCBs, their metabolites, and OCPs are negatively associated with tT~3~.

Thyroid parameters in Inuit adults were mostly affected by exposure to PFOS. Indeed, we found a negative association of PFOS concentrations with circulating TSH, tT~3,~ and TBG levels and a positive relationship with fT~4~. Toxicologic studies dedicated to investigating the thyroid-disrupting properties of PFOS are rare and focus mainly on maternal and fetal thyroid functions. In adult rats, PFOS was shown to compete with fT~4~ for transport proteins ([@b10-ehp-117-1380]), leading to a transient increase in fT~4~ and decrease in TSH concentrations. However, these authors also found a nontransient reduction in tT~4~ and tT~3~, with the latter being less affected. These results in laboratory animals are consistent with perturbations we observed on the TH homeostasis in Inuit, except that effects observed on the circulating concentrations of fT~4~ and TSH do not seem to be transient in our study.

Although exposure to PBDEs in Inuit men and women is lower than levels reported in other North American populations, we found a positive association of tT~3~ with BDE-47 but no association with BDE-153. These results differ from those observed in men from other fish-eating communities. Exposure to PBDEs was positively related to tT~4~, fT~4~, and urinary T~4~, as well as with reverse T~3~ levels, and negatively related to tT~3~ and TSH in Great Lake fish consumers ([@b36-ehp-117-1380]). In addition, fT~4~ and TSH were not associated with PBDEs in New York sport fish consumers ([@b7-ehp-117-1380]), whereas a negative association with TSH, but not fT~4,~ was reported in anglers from the Baltic Sea ([@b16-ehp-117-1380]). No other epidemiologic study assessed the potential effect of PBDEs on women's thyroid function. So far, associations observed in human studies are not consistent with effects observed in animal models. Exposure to PBDE commercial mixtures was systematically associated with decreased T~4~ concentrations, subtle variations of T~3,~ and unchanged TSH concentrations in rodents ([@b18-ehp-117-1380]; [@b41-ehp-117-1380]).

We observed similar associations between thyroid function parameters and concentrations of PCB congeners, their metabolites, and concentrations of OCPs and DLCs. This is not surprising because the Inuit population is exposed to a complex mixture of OCs, with concentrations of compounds being highly inter correlated. Consequently, it is almost impossible to isolate specific effects of PCB congeners and their metabolites, as well as OCPs, on the thyroid system in the context of epidemiologic studies in this population. TSH concentrations were lowered only by exposure to the most chlorinated PCB congeners and HO metabolites. Total T~3~ concentrations were negatively associated with almost all PCB congeners and their metabolites, as well as with OCPs and DLCs. Circulating levels of TBG, the predominant TH carrier protein in humans, were negatively associated with the less chlorinated PCBs, all HO-PCBs, and almost all other OCPs. Adjustment for other families of contaminants weakened some associations of PCB congeners and their metabolites as well as OCPs with TH parameters, probably because introduction of contaminants in regression models that were not associated with TH parameters added random variation in statistical models.

Most epidemiologic studies examining the relations between PCBs and thyroid function in adults reported no association with TSH and fT~4~ ([@b16-ehp-117-1380], [@b17-ehp-117-1380]; [@b25-ehp-117-1380]; [@b29-ehp-117-1380]; [@b30-ehp-117-1380]). Associations with tT~4~ and/or tT~3~ were reported to be negative in half of the studies, whereas the remaining studies found no relation with these hormones ([@b1-ehp-117-1380]). Interestingly, associations of PCBs with total T~3~ and T~4~ were never positive. Therefore, results from the present study are in accordance with most previous findings in human adults. The independent effect of PCB exposure on tT~3~ circulating levels was previously reported in American men from the general population of Boston, Massachusetts ([@b25-ehp-117-1380]), in obese men that underwent a weight-loss program ([@b27-ehp-117-1380]), and in fishermen's wives who consumed PCB-contaminated fish from the Baltic Sea ([@b17-ehp-117-1380]). Although the thyroid function of pregnant women and children may not be comparable because they may be more vulnerable to thyroid dysfunction, isolated effects on T~3~ concentrations have also been observed in pregnant Canadian women ([@b35-ehp-117-1380]), as well as in children from Germany and Spain ([@b3-ehp-117-1380]; [@b26-ehp-117-1380]).

Toxicologic studies with animal models have demonstrated differential mechanisms by which PCBs and OCPs induce perturbations of the thyroid system, mainly by reducing fT~4~ concentrations ([@b9-ehp-117-1380]; [@b11-ehp-117-1380]; [@b38-ehp-117-1380]). DLCs, including some PCB congeners, bind to the aryl hydrocarbon receptor (AhR) and activate the hepatic uridine diphosphate glucuronyltransferase (UDP-GT) enzymes responsible for T~4~ glucuronidation, resulting in T~4~ excretion in bile. Non-DL-PCBs do not cause AhR-dependent effects but induce microsomal cytochrome P450 enzymes 2B and 3A that may also reduce circulating T~4~ levels ([@b21-ehp-117-1380]). However, these mechanisms do not explain the selective effect of most PCBs and OCPs on tT~3~ concentrations observed in this study and others. One possible explanation could be that some of the compounds may affect peripheral deiodination of T~4~ by inactivation of deiodinase enzymes ([@b33-ehp-117-1380]), leading to reduced T~3~ levels. Also, some PCBs or their metabolites may alter the activities (activation or inactivation) of specific T~3~- or T~4~-directed hepatic UDP-GT enzymes, affecting principally the circulating levels of T~3~ ([@b39-ehp-117-1380]). However, we are unable to adequately evaluate those hypotheses because we did not measure tT4 in the course of this study. Another potential mechanism could be that those compounds primarily affect TBG concentrations, leading to a reduction in the TH-binding capacity of serum. Because serum THs are mainly bound to carrier proteins and TBG is the main transporter (75% T~4~ and 70% T~3~) ([@b32-ehp-117-1380]), such alterations could reduce total TH concentrations as we observed with tT~3~ in this study. Interestingly, individuals with inherited or acquired TBG excess have elevated total T~3~ and T~4~ concentrations, whereas those with TBG deficiency have decreased concentrations ([@b4-ehp-117-1380]). Nevertheless, those individuals are still considered euthyroid because of their normal TSH and fT~4~ levels. Similarly, PCBs or OCPs may affect TBG levels and consequently tT~3~ and tT~4~ without modifying TSH and fT~4~ concentrations. This potential mechanism could explain why most epidemiologic studies among adults reported negative associations with circulating tT~4~ and/or tT~3~ but no association with TSH and fT~4~.

We could not compare our results on the effect of PCBs on TBG concentrations in adults because TBG quantification was not performed in other epidemiologic studies. Explanations given for the negative associations between several PHCs and TBG concentrations observed in two previous studies ([@b13-ehp-117-1380], [@b14-ehp-117-1380]) and this one are unclear, but they suggest a decrease of TBG synthesis by the liver or an increase in catabolism. Unfortunately, such mechanisms cannot be corroborated by toxicologic data because studies have focused on the competitive binding assessment of contaminants with T~4~, without paying attention to their possible ability to modify transport protein synthesis.

In the present study, exposure to HCB was associated with reduced fT~4~ concentrations. Exposure to HCB was also related to a concomitant decline in tT~3~ and TBG, without association with TSH concentrations. HCB-treated rats usually showed a decline in fT~4~ and tT~4~ levels with no change in tT~3~ and inconsistent effects on TSH concentrations ([@b2-ehp-117-1380]; [@b38-ehp-117-1380]). Activation of hepatic UDP-GT enzymes by HCB, followed by T~4~ glucuronidation and subsequent biliary excretion, is the main mechanism explaining hypothyroidism state in rats. In humans, considering our findings, this contaminant may induce a reduction in TBG concentrations, which decreases the T~3~ and potentially T~4~ binding capacity of serum, whereas reduction of fT~4~ may be related to UDP-GT enzymes induction in the liver.

HO-PCBs and pentachlorophenol were not associated with a significant reduction in fT~4~ concentrations. Only one study has investigated the effect of HO-PCBs on thyroid homeostasis of fishermen consuming fish from the Baltic Sea, and no association was found ([@b16-ehp-117-1380]). Those compounds have been shown to be potent competitive inhibitors of T~4~ binding to transthyretin ([@b37-ehp-117-1380]), one of the TH carrier proteins, leading to increased T~4~ metabolism. However, because transthyretin contributes to only one-fifth of bound T~4~, this mechanism is less likely to have an impact on fT~4~ concentrations in adults. On the other hand, such a mechanism could be important in fetuses and neonates because transthyretin is involved in T~4~ placental transfer ([@b24-ehp-117-1380]) and transport through the blood--brain barrier ([@b31-ehp-117-1380]).

Results from the present study demonstrate that PHCs differentially alter the circulating levels of THs in humans. It is therefore extremely difficult to predict the total effect of exposure to a complex mixture of thyroid- disrupting chemicals on thyroid status. Assessments of effects of exposure to mixtures on the thyroid systems in animal models are scarce. In male rats, additivity under estimated the effect of a mixture of 16 OCs, lead, and cadmium on different thyroid end points ([@b40-ehp-117-1380]). Relationship between tT4 and exposure to a mixture of dioxins, furans, and PCBs in rats was shown to be additive at the lowest doses, but synergism was observed at higher doses ([@b12-ehp-117-1380]). From our results and those of others, there is increasing evidence that emerging persistent chemicals such as PBDEs and PFOS are also thyroid disrupting and should be included in future studies aiming to assess the potential effects of persistent organic pollutants on the thyroid system.

This study has several strengths that are worth mentioning. First, we used a sample-based sampling design and recruited a large number of participants. We considered confounding effects for an important number of covariates, including medication use and concomitant exposure to other PHCs. However, we were unable to evaluate the individual effect of OCs on TH status by controlling for other OCs because of the high intercorrelations between these compounds. One limitation of this study is that we did not use the equilibrium dialysis method that is less binding- protein dependent for fT4 quantification.

In summary, we observed a significant reduction of tT~3~ with exposure to several PCBs and their metabolites, as well as exposure to some OCPs. A large number of PHCs seem to modify circulating levels of TBG, the main TH transport protein in humans. In addition, we found that exposure to BDE-47 and PFOS, at levels observed in several populations worldwide, appear to modify levels of TH parameters. However, other epidemiologic, animal, and *in vitro* studies are needed to corroborate these results. Because most Inuit participants had a thyroid status within the euthyroid range, it is not clear if the observed effects could be associated with increasing disease burden in adults.

Supplemental Material is available online (doi:10.1289/ehp.0900633.S1 via <http://dx.doi.org/>).
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###### 

Characteristics of adult Inuit of Nunavik.

  Characteristic                                                                  No.   Percentage   Mean ± SD     Range
  ------------------------------------------------------------------------------- ----- ------------ ------------- ------------
  Sex (%)                                                                                                          
   Male                                                                           245   39.3                       
   Female                                                                         378   60.7                       
  Menopause (% among females)                                                                                      
   Yes                                                                            52    12.5                       
   No                                                                             363   87.5                       
  Age (years)                                                                     623                36.8 ± 13.9   18--73
  Body mass index (kg/m^2^)                                                       623                27.4 ± 5.7    17.2--48
  Selenium (μmol/L)                                                               622                4.4 ± 3.0     1.5--30.0
  No. of cigarettes/day (%)                                                                                        
   0                                                                              136   21.8                       
   1--10                                                                          187   30.0                       
   11--24                                                                         226   36.3                       
   ≥ 25                                                                           74    11.9                       
  Frequency of alcohol consumption (%)                                                                             
   Never or yearly                                                                287   49.4                       
   Monthly                                                                        148   25.8                       
   Weekly                                                                         101   17.4                       
   Daily                                                                          45    7.8                        
  Fish consumption (g/day)[a](#tfn1-ehp-117-1380){ref-type="table-fn"}            563                54.7 ± 75.1   0--665.6
  Marine mammal consumption (g/day)[a](#tfn1-ehp-117-1380){ref-type="table-fn"}   561                27.1 ± 44.4   0--398.7
  Education (%)                                                                                                    
   None                                                                           46    7.4                        
   Elementary school                                                              99    15.9                       
   High school                                                                    394   63.2                       
   University                                                                     84    13.5                       
  TSH (mIU/L)[b](#tfn2-ehp-117-1380){ref-type="table-fn"}                         623                1.18 ± 0.79   0.06--6.45
  fT~4~ (pmol/L)[b](#tfn2-ehp-117-1380){ref-type="table-fn"}                      621                15.5 ± 2.1    9.3--22.9
  tT~3~ (nmol/L)[b](#tfn2-ehp-117-1380){ref-type="table-fn"}                      621                2.14 ± 0.33   1.21--3.39
  TBG (μg/mL)[b](#tfn2-ehp-117-1380){ref-type="table-fn"}                         622                24.0 ± 6.0    8.0--62.8
  Medication use in the last 6 months (%)                                                                          
   Yes                                                                            106   17.0                       
   No                                                                             517   83.0                       

Expressed on an annual basis.

Laboratory euthyroid reference range: TSH, 0.27--4.20 mIU/L; fT~4~, 12--22 pmol/L; tT~3~, 1.3--3.1 nmol/L ; TBG, 13--30 μg/mL.

###### 

Plasma concentrations of PHCs in Inuit participants.

  Analyte                                                          No.   Percent detected   Geometric mean   95% CI           Range
  ---------------------------------------------------------------- ----- ------------------ ---------------- ---------------- -----------------
  PCB congener[a](#tfn4-ehp-117-1380){ref-type="table-fn"}                                                                    
   PCB-74                                                          623   95.0               8.92             8.15--9.75       \< LOD--218.77
   PCB-99                                                          623   99.7               25.53            23.38--27.87     \< LOD--849.53
   PCB-105                                                         623   78.4               3.49             3.10--3.93       \< LOD--100.74
   PCB-118                                                         623   99.8               22.76            20.79--24.91     \< LOD--497.09
   PCB-138                                                         623   100                78.03            71.41--85.26     3.66--1388.42
   PCB-146                                                         623   98.7               22.15            20.14--24.36     \< LOD--589.00
   PCB-153                                                         623   100                180.06           163.71--198.06   5.69--5805.15
   PCB-156                                                         623   87.7               6.70             5.97--7.51       \< LOD--330.97
   PCB-163                                                         623   99.2               26.88            24.39--29.63     \< LOD--807.77
   PCB-170                                                         623   99.4               25.88            23.42--28.61     \< LOD--869.17
   PCB-172                                                         621   78.7               3.95             3.49--4.47       \< LOD--180.20
   PCB-177                                                         623   82.7               3.96             3.56--4.41       \< LOD--89.13
   PCB-178                                                         623   90.1               7.83             7.01--8.73       \< LOD--235.60
   PCB-180                                                         623   100                93.28            84.53--102.93    3.25--3510.34
   PCB-183                                                         623   93.5               9.16             8.35--10.06      \< LOD--177.74
   PCB-187                                                         623   99.8               37.98            34.67--41.61     1.18--790.66
   PCB-194                                                         623   95.1               15.74            13.94--17.77     \< LOD--945.49
   PCB-201                                                         623   96.1               15.88            14.19--17.78     \< LOD--772.27
   PCB-203                                                         623   89.4               7.93             7.08--8.88       \< LOD--294.20
   PCB-206                                                         623   78.2               4.02             3.51--4.59       \< LOD--275.81
                                                                                                                              
  PCB grouping[a](#tfn4-ehp-117-1380){ref-type="table-fn"}                                                                    
   ∑PCBs                                                           621                      635.98           579.33--698.18   31.47--14260.92
   Mono-*ortho* PCB                                                623                      45.24            41.34--49.51     1.80--866.67
   DLCs[b](#tfn5-ehp-117-1380){ref-type="table-fn"}                607   72.6               10.62            10.04--11.23     \< LOD--139.30
                                                                                                                              
  HO-PCB[c](#tfn6-ehp-117-1380){ref-type="table-fn"}                                                                          
   3-HO-PCB-138                                                    562   89.0               30.38            27.17--33.98     \< LOD--980
   3-HO-PCB-153                                                    536   97.5               36.27            32.38--40.63     \< LOD--1,500
   4-HO-PCB-107                                                    566   99.5               173.21           158.67--189.08   \< LOD--3,200
   4-HO-PCB-146                                                    536   99.5               136.88           123.26--152.01   \< LOD--4,900
   4-HO-PCB-163                                                    567   94.0               11.20            10.20--12.29     \< LOD--590
   4-HO-PCB-172                                                    550   96.6               19.19            17.30--21.27     \< LOD--790
   4-HO-PCB-187                                                    567   99.8               157.69           143.67--173.07   \< LOD--4,300
   4-HO-PCB-199                                                    568   94.5               19.10            17.20--21.22     \< LOD--1,200
   4-HO-PCB-202                                                    566   87.9               8.42             7.66--9.26       \< LOD--340
   4-HO-PCB-208                                                    568   75.0               5.64             5.13--6.21       \< LOD--340
   ∑HO-PCBs                                                        536                      642.02           584.52--705.18   39.44--14,610
                                                                                                                              
  MeSO~2~-PCB[c](#tfn6-ehp-117-1380){ref-type="table-fn"}                                                                     
   3-MeSO~2~-PCB-49                                                573   93.4               26.39            23.77--29.30     \< LOD--910
   3-MeSO~2~-PCB-87                                                573   76.5               11.23            10.04--12.57     \< LOD--610
   3-MeSO~2~-PCB-101                                               575   86.9               18.50            16.55--20.68     \< LOD--920
   ∑MeSO~2~-PCBs                                                   573                      57.54            51.71--64.03     \< LOD--2,270
                                                                                                                              
  OC[a](#tfn4-ehp-117-1380){ref-type="table-fn"}                                                                              
   *p,p*′-DDE                                                      623   100                477.78           441.70--516.81   12.85--8306.48
   HCB                                                             623   99.7               61.36            56.38--66.78     \< LOD--1245.97
   Pentachlorophenol[c](#tfn6-ehp-117-1380){ref-type="table-fn"}   567   100                801.43           758.25--847.07   140--18,000
   β-HCH                                                           622   95.9               8.33             7.70--9.02       \< LOD--201.94
                                                                                                                              
  PBDE[a](#tfn4-ehp-117-1380){ref-type="table-fn"}                                                                            
   BDE-47                                                          623   57.3               2.16             1.84--2.54       \< LOD--343.45
   BDE-153                                                         623   73.8               2.05             1.85--2.27       \< LOD--75.74
                                                                                                                              
  Perfluorinated compound                                                                                                     
   PFOS[c](#tfn6-ehp-117-1380){ref-type="table-fn"}                621   100                18,280           17,190--19,440   480--470,000

Abbreviations: β-HCH, β-hexachlorocyclohexane; DDE, *p,p*′-dichlorodiphenyldichloroethylene; HCB, hexa chlorobenzene.

Lipid standardized concentrations (μg/kg).

Concentrations in picograms toxic equivalents per gram lipids.

Concentrations on a wet weight basis (ng/L).

###### 

Linear regression models of THs and TBG plasma levels with PCB and DLC concentrations (wet weight basis).

                             TSH                                                     fT~4~                                                    T~3~                                                     TBG                                                                                                                                                                          
  -------------------- ----- ------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- -------- ------------------------------------------------------ --------------------------------------------------------------------------------------------------- -------- --------------------------------------------------------------------------------------------------
  PCB congener                                                                                                                                                                                                                                                                                                                                                                      
   PCB-74              623   0.052[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.014                                                    −0.019[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.004   −0.028[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.020[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}                                                −0.001   −0.036[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}
   PCB-99              623   0.054[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.022                                                    −0.015[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.003    −0.025[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.012                                                                                              −0.004   −0.034[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}
   PCB-105             623   0.039[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.017                                                    −0.015[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.004   −0.021[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.018[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}                                              −0.001   −0.030[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}
   PCB-118             623   0.058[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.027                                                    −0.021[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.009   −0.030[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.028[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}                                              −0.005   −0.051[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}
   PCB-138             623   0.046[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     0.000                                                    −0.016[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     0.000    −0.027[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.015                                                                                              −0.001   −0.028[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}
   PCB-146             623   0.035[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     −0.023                                                   −0.016[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.004   −0.028[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.020[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}                                              −0.000   −0.026[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[a](#tfn8-ehp-117-1380){ref-type="table-fn"}
   PCB-153             623   0.033                                                   −0.024                                                   −0.014[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.001    −0.027[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.017[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[a](#tfn8-ehp-117-1380){ref-type="table-fn"}    0.001    −0.021
   PCB-156             623   0.021                                                   −0.035                                                   −0.012[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.003   −0.022[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.014[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[a](#tfn8-ehp-117-1380){ref-type="table-fn"}    0.005    −0.003
   PCB-163             623   0.039[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     −0.009                                                   −0.016[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.007   −0.028[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.023[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}                                              0.000    −0.024[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[a](#tfn8-ehp-117-1380){ref-type="table-fn"}
   PCB-170             623   0.026                                                   −0.040                                                   −0.014[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.004   −0.026[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.016[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[a](#tfn8-ehp-117-1380){ref-type="table-fn"}    0.007    −0.000
   PCB-172             621   0.025                                                   −0.019                                                   −0.010[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.000    −0.022[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.014[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}                                                0.004    −0.005
   PCB-177             623   0.036[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     −0.006                                                   −0.014[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.002   −0.024[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.015[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}                                                0.001    −0.018[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[b](#tfn9-ehp-117-1380){ref-type="table-fn"}
   PCB-178             623   0.021                                                   −0.039                                                   −0.014[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.007   −0.025[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.019[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}                                              0.003    −0.008
   PCB-180             623   0.020                                                   −0.059[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     −0.012[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.001    −0.025[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.011                                                                                              0.007    −0.000
   PCB-183             623   0.031                                                   −0.024                                                   −0.012[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.006    −0.025[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.011                                                                                              0.003    −0.017
   PCB-187             623   0.040[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     −0.013                                                   −0.017[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.006   −0.029[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.018[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[a](#tfn8-ehp-117-1380){ref-type="table-fn"}    0.001    −0.023
   PCB-194             623   0.008                                                   −0.069[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.011[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.003   −0.021[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.012[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[c](#tfn10-ehp-117-1380){ref-type="table-fn"}   0.007    0.005
   PCB-201             623   0.016                                                   −0.051[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     −0.012[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.003   −0.024[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.016[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}[a](#tfn8-ehp-117-1380){ref-type="table-fn"}    0.006    −0.003
   PCB-203             623   0.008                                                   −0.069[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.010[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.003    −0.021[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.008                                                                                              0.006    −0.000
   PCB-206             623   0.001                                                   −0.075[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   −0.009[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.004    −0.017[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.003                                                                                              0.011    0.013
                                                                                                                                                                                                                                                                                                                                                                                    
  PCB grouping                                                                                                                                                                                                                                                                                                                                                                      
   ∑PCBs               623   0.029                                                   −0.040                                                   −0.015[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.003   −0.029[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.020[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}                                                0.003    −0.017
   Mono-*ortho* PCBs   623   0.051[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}   0.009                                                    −0.021[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     −0.012   −0.031[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.028[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}                                                0.001    −0.037[\*\*](#tfn12-ehp-117-1380){ref-type="table-fn"}
   DLCs                607   0.092[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}     0.019                                                    −0.017[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}     0.007    −0.043[\#](#tfn13-ehp-117-1380){ref-type="table-fn"}   −0.027[\*](#tfn11-ehp-117-1380){ref-type="table-fn"}                                                −0.002   −0.027

All models adjusted for sex, age, body mass index, plasma lipids, cigarette consumption (cigarettes/day), and education. Associations remained significant after adjusting for fish and alcohol consumption, unless noted.

Borderline significant after adjusting for fish consumption (0.05 \< *p* \< 0.07).

Not significant after adjusting for alcohol consumption.

Not significant after adjusting for fish consumption.

*p* ≤ 0.05.

*p* \< 0.01.

*p* \< 0.001.

###### 

Linear regression models of THs and TBG plasma levels with HO-PCB and MeSO~2~-PCB concentrations (wet weight basis).

                             TSH                                                   fT~4~                                                    T~3~                                                     TBG                                                                                                                                                                          
  -------------------- ----- ----------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- -------- ------------------------------------------------------ --------------------------------------------------------------------------------------------------- -------- ---------------------------------------------------------------------------------------------------
  HO compound                                                                                                                                                                                                                                                                                                                                                                     
   3-HO-PCB-138        562   0.033[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}   −0.009                                                   −0.014[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}   −0.003   −0.031[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.027[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}                                                −0.002   −0.021[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}[a](#tfn15-ehp-117-1380){ref-type="table-fn"}
   3-HO-PCB-153        536   0.029                                                 −0.017                                                   −0.009                                                   0.008    −0.028[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.023[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}                                              −0.001   −0.027[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}[b](#tfn16-ehp-117-1380){ref-type="table-fn"}
   4-HO-PCB-107        566   0.020                                                 −0.020                                                   −0.011[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     0.009    −0.029[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.013                                                                                              −0.016   −0.052[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}
   4-HO-PCB-146        536   0.025                                                 −0.025                                                   −0.014[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}   −0.003   −0.028[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.018[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}[b](#tfn16-ehp-117-1380){ref-type="table-fn"}   0.000    −0.023[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}[b](#tfn16-ehp-117-1380){ref-type="table-fn"}
   4-HO-PCB-163        567   0.023                                                 −0.052                                                   −0.015[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}   −0.002   −0.032[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.020[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}                                                −0.004   −0.023
   4-HO-PCB-172        550   0.027                                                 −0.028                                                   −0.012[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     0.002    −0.031[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.024[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}                                              −0.001   −0.021
   4-HO-PCB-187        567   0.023                                                 −0.052                                                   −0.014[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     −0.000   −0.033[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.022[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}                                                −0.006   −0.029[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}[b](#tfn16-ehp-117-1380){ref-type="table-fn"}
   4-HO-PCB-199        568   0.008                                                 −0.084[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}   −0.010[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     0.003    −0.027[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.014                                                                                              0.001    −0.008
   4-HO-PCB-202        566   0.019                                                 −0.056                                                   −0.013[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     −0.001   −0.033[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.023[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}                                              −0.001   −0.016
   4-HO-PCB-208        568   0.006                                                 −0.084[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     −0.011[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     0.002    −0.027[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.011                                                                                              0.003    −0.007
   ∑HO-PCBs            536   0.035                                                 −0.025                                                   −0.015[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}     0.000    −0.033[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.025[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}                                                −0.002   −0.034[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                  
  MeSO~2~-PCB                                                                                                                                                                                                                                                                                                                                                                     
   3-MeSO~2~-PCB-49    573   0.040[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}   −0.007                                                   −0.018[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}     −0.008   −0.028[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.019[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}                                              0.003    −0.011
   3-MeSO~2~-PCB-87    573   0.040[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}   0.002                                                    −0.018[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}     −0.010   −0.026[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.017[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}                                              0.003    −0.011
   3-MeSO~2~-PCB-101   575   0.037[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}   −0.009                                                   −0.017[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}     −0.008   −0.026[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.016[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}                                                0.006    −0.004
   ∑MeSO~2~-PCBs       573   0.041[\*](#tfn17-ehp-117-1380){ref-type="table-fn"}   −0.006                                                   −0.018[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}     −0.009   −0.028[\#](#tfn19-ehp-117-1380){ref-type="table-fn"}   −0.018[\*\*](#tfn18-ehp-117-1380){ref-type="table-fn"}                                              0.005    −0.008

All models adjusted for sex, age, body mass index, plasma lipids, cigarette consumption (cigarettes/day), and education. Associations remained significant after adjusting for fish and alcohol consumption unless noted.

Not significant after adjusting for fish consumption.

Borderline significant after adjusting for fish consumption (0.05 \< *p* \< 0.07).

*p* ≤ 0.05.

*p* \< 0.01.

*p* \< 0.001.

###### 

Linear regression models of THs and TBG plasma levels with OCPs, PBDE, and PFOS concentrations (wet weight basis).

                                  TSH                                                   fT~4~                                                  T~3~                                                    TBG                                                                                                                                                                                                                                                                         
  ------------------------- ----- ----------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------------------------------------------------------
  OC                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
   *p,p*′-DDE               623   0.051[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}   0.012                                                  −0.021[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}    −0.007                                                   −0.030[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}   −0.016                                                                                               −0.001                                                 −0.030[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}[a](#tfn21-ehp-117-1380){ref-type="table-fn"}
   HCB                      623   0.048[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}   0.010                                                  −0.026[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}    −0.017[\*\*](#tfn24-ehp-117-1380){ref-type="table-fn"}   −0.033[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}   −0.030[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}                                                 −0.006                                                 −0.054[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}
   Pentachlorophenol        567   0.008                                                 −0.001                                                 0.022[\*\*](#tfn24-ehp-117-1380){ref-type="table-fn"}   0.014                                                    −0.008                                                 −0.009                                                                                               −0.037[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}   −0.021
   β-HCH                    622   0.081[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}   0.047                                                  −0.022[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}    −0.008                                                   −0.032[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}   −0.028[\*\*](#tfn24-ehp-117-1380){ref-type="table-fn"}                                               −0.007                                                 −0.051[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  PBDE                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
   BDE-47                   623   0.000                                                 −0.002                                                 0.002                                                   0.001                                                    0.010[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}    0.008[\*\*](#tfn24-ehp-117-1380){ref-type="table-fn"}[b](#tfn22-ehp-117-1380){ref-type="table-fn"}   0.002                                                  0.003
   BDE-153                  623   0.017                                                 −0.009                                                 0.007                                                   0.009                                                    −0.001                                                 0.005                                                                                                −0.002                                                 0.005
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Perfluorinated compound                                                                                                                                                                                                                                                                                                                                                                                                                                                          
   PFOS                     621   −0.017                                                −0.102[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}   0.004                                                   0.014[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}      −0.030[\#](#tfn25-ehp-117-1380){ref-type="table-fn"}   −0.017[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}                                                 −0.026[\*](#tfn23-ehp-117-1380){ref-type="table-fn"}   −0.034[\*\*](#tfn24-ehp-117-1380){ref-type="table-fn"}

All models adjusted for sex, age, body mass index, plasma lipids, cigarette consumption (cigarettes/day), and education. Associations remain significant after adjusting for fish and alcohol consumption unless noted.

Borderline significant after adjusting for alcohol consumption (0.05 \< *p* \< 0.07).

Borderline significant after adjusting for fish consumption (0.05 \< *p* \< 0.07).

*p* ≤ 0.05.

*p* \< 0.01.

*p*\< 0.001.

[^1]: The authors declare they have no competing financial interests.
